AU2017220785B2 - Method and system for early risk assessment of preterm delivery outcome - Google Patents

Method and system for early risk assessment of preterm delivery outcome Download PDF

Info

Publication number
AU2017220785B2
AU2017220785B2 AU2017220785A AU2017220785A AU2017220785B2 AU 2017220785 B2 AU2017220785 B2 AU 2017220785B2 AU 2017220785 A AU2017220785 A AU 2017220785A AU 2017220785 A AU2017220785 A AU 2017220785A AU 2017220785 B2 AU2017220785 B2 AU 2017220785B2
Authority
AU
Australia
Prior art keywords
abundance
value
taxonomic
values
microbial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017220785A
Other languages
English (en)
Other versions
AU2017220785A1 (en
Inventor
Anirban Dutta
Mohammed Monzoorul Haque
Sharmila Shekhar Mande
Mitali MERCHANT
Nishal Kumar PINNA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tata Consultancy Services Ltd
Original Assignee
Tata Consultancy Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tata Consultancy Services Ltd filed Critical Tata Consultancy Services Ltd
Publication of AU2017220785A1 publication Critical patent/AU2017220785A1/en
Application granted granted Critical
Publication of AU2017220785B2 publication Critical patent/AU2017220785B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4343—Pregnancy and labour monitoring, e.g. for labour onset detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Data Mining & Analysis (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Artificial Intelligence (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
AU2017220785A 2016-02-16 2017-02-15 Method and system for early risk assessment of preterm delivery outcome Active AU2017220785B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201621005426 2016-02-16
IN201621005426 2016-02-16
PCT/IB2017/050840 WO2017141169A1 (en) 2016-02-16 2017-02-15 Method and system for early risk assessment of preterm delivery outcome

Publications (2)

Publication Number Publication Date
AU2017220785A1 AU2017220785A1 (en) 2018-09-27
AU2017220785B2 true AU2017220785B2 (en) 2019-02-21

Family

ID=59624818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017220785A Active AU2017220785B2 (en) 2016-02-16 2017-02-15 Method and system for early risk assessment of preterm delivery outcome

Country Status (7)

Country Link
US (1) US11062808B2 (enExample)
EP (1) EP3416653B1 (enExample)
JP (1) JP7060518B2 (enExample)
CN (1) CN108778287B (enExample)
AR (1) AR107737A1 (enExample)
AU (1) AU2017220785B2 (enExample)
WO (1) WO2017141169A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2699733C1 (ru) * 2018-03-30 2019-09-09 Федеральное государственное бюджетное образовательное учреждение высшего образования "Московская государственная академия ветеринарной медицины и биотехнологии - МВА имени К.И. Скрябина" (ФГБОУ ВО МГАВМиБ - МВА имени К.И. Скрябина) Способ лабораторной ультразвуковой диагностики ранних стадий жеребости
EP3620539B1 (en) * 2018-08-10 2026-01-14 Tata Consultancy Services Limited Method and system for improving amplicon sequencing based taxonomic resolution of microbial communities
GB2612911B (en) 2019-02-14 2023-11-22 Mirvie Inc Methods and systems for determining a pregnancy-related state of a subject
CN112587089B (zh) * 2020-11-19 2023-04-21 新希望六和股份有限公司 基于人工智能的妊娠检测方法、装置、计算机设备和介质
EP4308017A4 (en) * 2021-03-18 2025-02-12 The Board of Trustees of the Leland Stanford Junior University Systems and methods to generate a surgical risk score and uses thereof
US20230038921A1 (en) * 2021-06-03 2023-02-09 Tata Consultancy Services Limited System and method for estimation of delivery date of pregnant subject using microbiome data
KR102559223B1 (ko) * 2021-07-19 2023-07-26 주식회사 디앤피바이오텍 기계 학습에 기반한 조산 위험도 예측 장치
US11664100B2 (en) * 2021-08-17 2023-05-30 Birth Model, Inc. Predicting time to vaginal delivery
KR102916736B1 (ko) 2022-04-21 2026-01-23 이화여자대학교 산학협력단 마이크로바이옴을 분석하는 학습 모델을 이용한 조산 예측 방법 및 분석장치
CN115227295B (zh) * 2022-09-19 2023-01-24 深圳市雄帝科技股份有限公司 咽拭子采样设备

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060172330A1 (en) * 2005-01-14 2006-08-03 Idaho Research Foundation And Procter & Gamble Categorization of microbial communities
US20090299212A1 (en) * 2006-12-11 2009-12-03 Principe Jose C System and Method for Analyzing Progress of Labor and Preterm Labor
US20110152840A1 (en) * 2009-12-23 2011-06-23 Drugtech Corporation Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
US20120270747A1 (en) * 2009-10-29 2012-10-25 The Trustees Of The University Of Pennsylvania Method of predicting risk of pre-term birth
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
US20140287948A1 (en) * 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
WO2014152985A1 (en) * 2013-03-14 2014-09-25 Children's Hospital Medical Center Biomarkers of preterm necrotizing enterocolitis
WO2015153841A1 (en) * 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
EP2283155A4 (en) * 2008-05-01 2011-05-11 Swedish Health Services DIAGNOSTIC TEST FOR BREAKFAST
US10633714B2 (en) * 2013-07-21 2020-04-28 Pendulum Therapeutics, Inc. Methods and systems for microbiome characterization, monitoring and treatment
KR102207858B1 (ko) * 2014-06-30 2021-01-26 더 차이니즈 유니버시티 오브 홍콩 유해 임신 결과를 예측하기 위한 박테리아 분류군의 검출

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060172330A1 (en) * 2005-01-14 2006-08-03 Idaho Research Foundation And Procter & Gamble Categorization of microbial communities
US20090299212A1 (en) * 2006-12-11 2009-12-03 Principe Jose C System and Method for Analyzing Progress of Labor and Preterm Labor
US20120270747A1 (en) * 2009-10-29 2012-10-25 The Trustees Of The University Of Pennsylvania Method of predicting risk of pre-term birth
US20110152840A1 (en) * 2009-12-23 2011-06-23 Drugtech Corporation Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
US20140186332A1 (en) * 2012-12-28 2014-07-03 NX Pharmagen Biomarkers of preterm birth
WO2014152985A1 (en) * 2013-03-14 2014-09-25 Children's Hospital Medical Center Biomarkers of preterm necrotizing enterocolitis
US20140287948A1 (en) * 2013-03-15 2014-09-25 Sera Prognostics, Inc. Biomarkers and methods for predicting preterm birth
WO2015153841A1 (en) * 2014-04-04 2015-10-08 Ritter Pharmaceuticals, Inc. Methods and compositions for microbiome alteration

Also Published As

Publication number Publication date
JP7060518B2 (ja) 2022-04-26
EP3416653A4 (en) 2019-06-19
CN108778287A (zh) 2018-11-09
EP3416653A1 (en) 2018-12-26
US20190046105A1 (en) 2019-02-14
WO2017141169A1 (en) 2017-08-24
AR107737A1 (es) 2018-05-30
CN108778287B (zh) 2021-08-31
AU2017220785A1 (en) 2018-09-27
JP2019511922A (ja) 2019-05-09
EP3416653B1 (en) 2022-05-25
US11062808B2 (en) 2021-07-13

Similar Documents

Publication Publication Date Title
AU2017220785B2 (en) Method and system for early risk assessment of preterm delivery outcome
Serrano et al. Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy
Walther-António et al. Pregnancy's stronghold on the vaginal microbiome
Porreco et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA
Norton et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18
Drell et al. Characterization of the vaginal micro-and mycobiome in asymptomatic reproductive-age Estonian women
Vogtmann et al. Comparison of collection methods for fecal samples in microbiome studies
Mehta et al. The vaginal microbiota over an 8-to 10-year period in a cohort of HIV-infected and HIV-uninfected women
Sinha et al. Quantification of human microbiome stability over 6 months: implications for epidemiologic studies
Hopkins et al. Obesity and no call results: optimal timing of cell-free DNA testing and redraw
US20220243247A1 (en) Vaginal microbiome markers for prediction of prevention of preterm birth and other adverse pregnancy outcomes
EP3023504B1 (en) Method and device for detecting chromosomal aneuploidy
Xu et al. Informative priors on fetal fraction increase power of the noninvasive prenatal screen
EP4099335A1 (en) System and method for estimation of delivery date of pregnant subject using microbiome data
Bybjerg-Grauholm et al. RNA sequencing of archived neonatal dried blood spots
Levine-Tiefenbrun et al. Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis
CN116779077A (zh) 基于体检标志物构建生物学年龄及衰老评价的方法及系统
Davidson et al. Methodological approaches in 16S sequencing of female reproductive tract in fertility patients: a review
Mitnitski Epigenetic biomarkers for biological age
Benn Posttest risk calculation following positive noninvasive prenatal screening using cell-free DNA in maternal plasma
Schor et al. Using machine learning to predict the risk of developing hypertensive disorders of pregnancy using a contemporary nulliparous cohort
US20240290488A1 (en) Systems and methods for determining oral microbiome compositions and health outcomes
Valinetz et al. Isoniazid preventive therapy and tuberculosis transcriptional signatures in people with HIV
Chowdhury et al. Asymptomatic SARS-CoV-2 infections tend to occur less frequently in developed nations
US20230035343A1 (en) Method for predicting onset of chorioamnionitis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)